AstraZeneca to Open New Bioinformatics Center in St. Petersburg | GenomeWeb

In a bid to strengthen its investment in Russia’s pharmaceutical market, AstraZeneca plans to establish a bioinformatics-based Predictive Science Center in St. Petersburg over the coming year.

As part of an agreement with the St. Petersburg government, the center will hire 30 people through collaborations with local companies and organizations to develop bioinformatics, data analysis methods, software, and systems to better predict the safety and efficacy of potential new medicines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.